Poietis - About the company
Poietis is a series A company based in Pessac (France), founded in 2014 by Fabien Guillemot. It operates as a Laser-assisted 3D bioprinting technology. Poietis has raised $9.01M in funding. The company has 2023 active competitors, including 467 funded and 348 that have exited. Its top competitors include companies like Sutro Biopharma, Synthego and Avidity Biosciences.
Company Details
Poietis develops and produces human, customized tissues using 4D bioprinting for pharmaceutical and cosmetic applications as well as regenerative medicine. Complex 3D tissues are obtained by high resolution Laser-Assisted Bioprinting. Poietis is the result of over 10 years of research conducted at INSERM (France’s National Institute for Health and Medical Research) and the University of Bordeaux. Poietis’ pioneering laser 3D printing technology stands out because it allows them to assemble live cells into pre-determined 3D structures with a resolution of up to 20 micrometers. The company has signed a major R&D agreement with leading chemical firm BASF to develop advanced 3D printed skincare applications.
- Website
- www.poietis.com
- Social
- Email ID
- *****@poietis.com
- Phone Number
- +33 **********
Key Metrics
Founded Year
2014
Location
Pessac, France
Stage
Series A
Total Funding
$9.01M in 6 rounds
Latest Funding Round
Ranked
293rd among 2023 active competitors
Employee Count
14 as on May 31, 2026
Similar Companies
Sign up to download Poietis' company profile
Poietis's funding and investors
Poietis has raised a total funding of $9.01M over 6 rounds. Its first funding round was on Dec 17, 2015. Its latest funding round was a Grant (prize money) round on Sep 01, 2022 for $*****. 1 investor participated in its latest round. Poietis has 2 institutional investors.
Here is the list of recent funding rounds of Poietis:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 01, 2022 | 9543422 | Grant (prize money) | 8632476 | 5318984 | 1472395 | 1212650 |
Jan 01, 2020 | 3221951 | Grant (prize money) | 3100279 | 7890457 | 2254039 | |
Oct 01, 2018 | 5485334 | Grant (prize money) | 9520790 | 8618618 | 6700471 |
Access funding benchmarks and valuations. Sign up today!View details of Poietis's funding rounds and investors
Poietis' founders and board of directors
Founder? Claim ProfileThe founders of Poietis is Fabien Guillemot.
Here are the details of Poietis' key team members:
- Fabien Guillemot: Co-Founder & CEO of Poietis. Contact Info: 1 email address
View details of Poietis's Founder profiles and Board Members
Poietis' employee count trend
Poietis has 14 employees as of May 26. Here is Poietis's employee count trend over the years:
Uncover Poietis' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Poietis's Competitors and alternates
Top competitors of Poietis include Sutro Biopharma, Synthego and Avidity Biosciences. Here is the list of Top 10 competitors of Poietis, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
2nd | Synthego 2012, Redwood City (United States), Acquired | Developer of CRISPR-engineered cell and gene therapies | $460M | 71/100 | |
3rd |  Avidity Biosciences 2012, San Diego (United States), Acquired | RNA therapeutics innovator targeting muscle and other diseases with AOC platform | $143M | 70/100 | |
4th | Aspect Biosystems 2013, Vancouver (Canada), Series B | Developer of bioprinting technology and tissue therapeutics for regenerative medicine | $139M | 67/100 | |
5th | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
6th | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
7th | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
8th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
9th | Life Biosciences 2017, Boston (United States), Series D | Biotechnology pioneering cellular rejuvenation therapies to reverse and prevent aging diseases | $261M | 64/100 | |
10th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
293rd | Laser-assisted 3D bioprinting technology | $9.01M | 40/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Poietis's competitors? Click here to see the top ones
Poietis's Investments and acquisitions
Poietis has made no investments or acquisitions yet.
News related to Poietis
Filter this list•
Marseille hospitals collaborate with the start-up Poietis for the 3D printing of human tissuesusine-digitale.fr•Nov 25, 2021•Poietis, AP-HM
•
•
Poietis granted third European patent for laser-assisted 3D bioprinting technologysmart-techub.eu•May 24, 2019•Poietis
•
•
•
•
•
This Liver Model Made With 4D Bioprinting Could Improve Drug Toxicity TestingLabiotech•Sep 19, 2018•Poietis, Servier
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Poietis
Explore our recently published companies
- MGI Software - San Francisco based, Funding Raised company
- Bill Orbit - Noida based, 2023 founded, Unfunded company
- Docket Care - Lucknow based, 1993 founded, Unfunded company
- Swisscast SA - Switzerland based, 2020 founded, Unfunded company
- Arrcadia Leisure Journey - Chandigarh based, 2012 founded, Unfunded company
- Stallion Institute of International Studies - Chandigarh based, 2015 founded, Unfunded company
